CIK 0001681682
- Non-accelerated filer
- Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 260579295
- Phone
- +1 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Open-market buy Director bought 500 shares at $1.14 ($570)
- 4 Open-market buy Director bought 9,500 shares at an average $1.11 ($10,582)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Technology Officer bought 30,000 shares at $1.13 ($33,900)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Chief Financial Officer acquired 5,953 shares (conversion)
- 4 Conversion Chief Technology Officer acquired 29,762 shares (conversion)
- 4 Conversion Chief Executive Officer acquired 5,953 shares (conversion)
- 4 Conversion Director acquired 59,524 shares (conversion)
- 4 Open-market sale 10% owner sold 130,200 shares at an average $4.19 ($545,246)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 9 · 174 filings